Capula secures GlaxoSmithKline as new customer

03 Apr 2003

Capula, an IT Services and Solutions company, have been awarded an order by GlaxoSmithKline (GSK) for a Materials Verification System.

The project (valued at £400k) is to install a new system for the Materials Handling Facility at GSK Ware. The new system will be developed in accordance with 'GAMP4' guidelines and be compliant with FDA ruling 21CFR (Part 11) and validated in accordance with FDA and MCA requirements.

The main aspects of the system will be to provide workstations, interface directly to the plant or local PLC to track all material moves or processing, interface to the trolley systems to inhibit any unauthorised moves, provide a secure repository for the GMP critical data and maintain the integrity of the data in the event of plant operation failure.

Commenting on the order, Capula Business Development Director, Tony Pegg said:

"The stringent regulatory and compliance environment within the Pharmaceuticals industry demands that suppliers of IT systems to the sector are capable of meeting these important regulatory demands. Capula is pleased to have been awarded such an important and high profile project, and it is testimony to our reputation for quality and attention to detail"

Capula, based in Stone, Staffordshire employs 300+ people in four offices around the UK. Providing IT solutions for business critical applications in Industry, Public/Healthcare, Utilities and Infrastructure and Energy, Capula have an enviable track record for delivering project to specification, on time every time.

Share: